Coronavirus Live News Updates: Rejecting BJP’s allegations of APP politicising the shortage of vaccines, the Delhi chief minister said that his govt just want vaccines for the National Capital Territory
Coronavirus Latest News Updates: Amid an acute shortage of vaccines, Delhi Chief Minister Arvind Kejriwal on Saturday asked the Centre to buy vaccines and distribute them to the state governments, and said this is not the time for blame game and petty politics.
Kejriwal said the AAP government “just wants vaccines” for Delhi and sought to know where is the politicisation in that.
Tamil Nadu Chief Minister MK Stalin has announced that children orphaned or those who lost either of their parents to coronavirus will be provided an assistance of Rs 5 lakhs. Further, the state government will bear all expenses towards their education till graduation.
A Delhi court on Saturday granted bail to businessman Navneet Kalra in a case pertaining to the seizure of oxygen concentrators from his upscale restaurants, including Khan Chacha, in the National Capital.
Delhi on Saturday recorded 956 fresh COVID-19 cases, the lowest in over two months, and 122 more fatalities while the positivity rate slipped to 1.19 percent, according to health department data.
The Goa government on Saturday decided to extend the ongoing “corona curfew”, which was supposed to be lifted on 31 May, by another week till 7 June. Formal orders on the extension of the corona curfew will be issued by collectors of South Goa and North Goa districts, the Chief Minister’s Office (CMO) said.
Union Minister Mansukh Mandaviya on Saturday tweeted that the Centre will discontinue the allocation of remdesvir to the state governments. He added that the production of the anti-viral drug had been ramped up.
“I am delighted and satisfied to inform you all that the Production of Remdesivir is ramped up ten times from just ~33,000 vials/day on 11th April 2021 to ~3,50,000 vials/day today,” he said.
“So we have decided to DISCONTINUE the Central Allocation of Remdesivir to States,” he added.
The Delhi government on Saturday invited bids for global tender for procurement of 10 million doses of COVID-19 vaccine. Last date for bidding is 7 June.
“At 1.73 lakh daily new cases, a declining trend in new cases is maintained. Active caseload further declines to 22,28,724 with active cases decrease by 1,14,428 in last 24 hours,” the Union health ministry said in its 8 am update on the COVID-19 situation in the country on Saturday.
The tally of new COVID-19 cases in the country was 173,921 in the last 24 hours, reports said on Saturday morning. This is the second consecutive day that the number of new cases are below two lakhs, The Times of India reported.
The state-wide lockdown without relaxations to help break the chain of COVID-19 transmission has been extended till June 7 by one more week, Chief Minister M K Stalin announced on Friday.
The lockdown-like-restrictions in Maharashtra on account of the coronavirus pandemic have been extended by 15 days but a fresh set of guidelines will be issued on 1 June, health minister Rajesh Tope said on Friday.
The state cabinet had taken the decision to extend the curbs on people’s movement and businesses — in force since mid-April — in a meeting on Thursday.
“As far as lockdown is concerned, 15 days’ extension has been given, but the guidelines related to it will be issued on 1 June,” Tope told reporters.
Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday.
The ministry said Government of India, through the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), is regularly interacting with national and international manufacturers like Pfizer, Moderna to make vaccines available in the country.
“The concrete actions are a stern indication that Government of India is making all out efforts to increase vaccine production in the country as well as attracting foreign vaccine manufacturers to supply the required vaccine doses for national Covid vaccination programme,” the ministry in a statement.
Despite the constraints of availability, India has fared well in covering 200 million persons in only 130 days which is the third largest coverage in the world, the ministry said.
Government of India has been supporting the efforts of states and UTs for effective management of Covid patients in vaccination under the ‘Whole of Government’ approach since January this year.
With Covid being a pandemic with worldwide impact, there has been a high global demand of vaccines with a limited number of manufacturers and limited manufacturing capacity across countries. India has a population of 1.4 billion, which is a substantial share of the world population, the statement said.
In India, two vaccines were approved by the regulatory body in January. The two manufacturers, Serum Institute and Bharat Biotech, had a capacity to provide around 1 crore doses in the month of December, 2020.
The NEGVAC was established in August, 2020 to provide guidance on all aspects of vaccine introduction, including prioritisation of beneficiaries, procurement, vaccine selection and its delivery.
The priority of beneficiaries for COVID-19 vaccination in India has been done based on the review of available scientific evidence, guidelines proposed by the WHO, global examples and practices followed in other countries with the primary objective of protecting the healthcare and frontline workers.
Accordingly, the vaccination drive in the country has been sequentially expanded to cover the prioritized groups starting with healthcare workers (HCWs) on January 16 followed by frontline workers (FLWs) from February 2, persons aged 60 years and above, and those aged 45-59 years with co-morbidities were covered from 1 March.
Subsequently, from 1 April everyone aged 45 and above are eligible for vaccination.
Such an approach has yielded positive results by achieving more than 90 percent first dose coverage among registered HCWs and around 84 per centcoverage of 1st dose among registered FLWs, the statement said.
A ‘Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy’ was adopted on May 1 which is guiding the ongoing phase of the vaccination drive.
This strategy aims at incentivising manufacturers to ramp up vaccine production and also attract new manufacturers. This will augment vaccine production resulting in wider availability of vaccines with flexibility in pricing, procurement, the statement said.
“The manufacturing capacities have been ramped up. Vaccine being a biological product takes time for harvesting and quality testing. This cannot be done overnight to ensure a safe product. Thus, increase in capacity of manufacturing too needs to be a guided process,” the statement said.
The Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for restricted use in emergency situation and it is being used in a few private hospitals. These are expected to be increased over the coming days.
Credit: Source link